Butyrylcholinesterase Levels on Admission Predict Severity and 12-Month Mortality in Hospitalized AIDS Patients
Background. Butyrylcholinesterase (BChE) is synthesized mainly in the liver and an important marker in many infectious/inflammatory diseases, but its role in acquired immunodeficiency syndrome (AIDS) patients is not clear. We wished to ascertain if BChE level is associated with the progression/progn...
Saved in:
Main Authors: | Lijun Xu, Biao Zhu, Ying Huang, Zongxing Yang, Jia Sun, Yan Xu, Jinlei Zheng, Sabine Kinloch, Michael T. Yin, Honglei Weng, Nanping Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2018/5201652 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reduced Serum Butyrylcholinesterase Activity Indicates Severe Systemic Inflammation in Critically Ill Patients
by: Aleksandar R. Zivkovic, et al.
Published: (2015-01-01) -
A Butyrylcholinesterase Camera Biosensor Tested for Carbofuran and Paraoxon Assay
by: Miroslav Pohanka, et al.
Published: (2022-01-01) -
Plasma IL-6/IL-10 Ratio and IL-8, LDH, and HBDH Level Predict the Severity and the Risk of Death in AIDS Patients with Pneumocystis Pneumonia
by: Jia Sun, et al.
Published: (2016-01-01) -
Resveratrol-Based Carbamates as Selective Butyrylcholinesterase Inhibitors: Design, Synthesis, Computational Study and Biometal Complexation Capability
by: Maja Sviben, et al.
Published: (2025-01-01) -
Machine learning cluster analysis identifies increased 12-month mortality risk in transcatheter aortic valve replacement recipients
by: Thomas Meredith, et al.
Published: (2025-02-01)